US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28

0.0000

Volume:- -

Turnover:- -

Market Cap:1.60M

PE:- -

High:53.28

Open:53.28

Low:53.28

Close:53.28

52wk High:56.90

52wk Low:44.36

Shares:30.00K

Float Shares:10.00K

Volume Ratio:2.68

T/O Rate:- -

Dividend:0.58

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug

MT Newswires Live

AstraZeneca Halts Russian NMOSD Study: What It Means for AZN Investors

Astrazeneca PLC Stock Falls Monday, Underperforms Market

Market Chatter: AstraZeneca Unit Highlights Opportunities in Rare Diseases

MT Newswires Live

AstraZeneca’s New Saruparib Trial Targets Next Wave of Prostate Cancer Growth

AstraZeneca’s ALICIA Real‑World CLL Study Wraps Up, Setting Up Fresh Data for AZN Investors

European Pharma Stocks' Underperformance Shouldn't Last

Morgan Stanley Remains a Buy on AstraZeneca (AZN)

AstraZeneca price target lowered to 15,300 GBp at Morgan Stanley

Astrazeneca PLC Stock Rises Thursday, Outperforms Market

AstraZeneca’s Eluminate-4 Trial Targets High-Risk Diabetes Patients, Raising Long-Term Upside for AZN

Dizal Pharmaceutical Announces Uncertainty Regarding the Effectiveness of Its Licensing Agreement with AstraZeneca

AstraZeneca Advances AZD7760 Trial in Japan, Quietly Expanding Its Infection-Prevention Pipeline

Astrazeneca Slides Tuesday, Underperforms Market

AstraZeneca to acquire rights to develop, commercialize Zegfrovy for $600M

Astrazeneca Complements Lung-cancer Franchise with New Licensing Deal

AstraZeneca Licenses Zegfrovy From Dizal in Up to $1.5 Billion Deal

MT Newswires Live

Innovative Drug Stock Surges to 20% Daily Limit in 14 Seconds

AstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors

Astrazeneca PLC Stock Falls Monday, Underperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AZNH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1787342400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-21 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653527037","title":"Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2653527037","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653527037?lang=en_us&edition=fundamental","pubTime":"2026-07-22 19:37","pubTimestamp":1784720239,"startTime":"0","endTime":"0","summary":"Royalty Pharma (RPRX) said Wednesday that it will pay up to $425 million, including a $125 million upfront payment, to biopharmaceutical company Neurimmune for a 3% to 4% royalty on worldwide net sale","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","AZN","LU2462157665.USD","PBE","LU0310800379.SGD","LU0432979614.USD","BK4585","LU2237443622.USD","LU2089984988.USD","BK4568","LU2456880835.USD","BK4007","LU2237443978.SGD","LU2237443895.HKD","LU0289739699.SGD","LU2417539215.USD","LU2237443549.SGD","IE00B3T34201.USD","LU0320765992.SGD","LU0708994859.HKD","LU0128525929.USD","RPRX","LU2468319806.SGD","AZNH","LU2237443382.USD","LU1829250122.USD","LU2236285917.USD","BK4588","LU0029864427.USD","IHE","LU1267930573.SGD","LU0058720904.USD","LU2237443465.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204833","title":"AstraZeneca Halts Russian NMOSD Study: What It Means for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204833","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204833?lang=en_us&edition=fundamental","pubTime":"2026-07-22 00:30","pubTimestamp":1784651416,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study titled “A Multicenter Non-interventional Single-arm Retrospectiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-halts-russian-nmosd-study-what-it-means-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-halts-russian-nmosd-study-what-it-means-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4211","LU0310800379.SGD","LU0109394709.USD","LU0029864427.USD","IE00B3T34201.USD","LU2237443465.HKD","BK4568","LU0289739699.SGD","LU2237443382.USD","LU2237443622.USD","LU0128525929.USD","LU0320765992.SGD","LU0432979614.USD","LU2417539215.USD","AZNH","LU2237443978.SGD","LU1267930573.SGD","LU0708994859.HKD","LU2089984988.USD","BK4007","LU2236285917.USD","ISBC","LU1829250122.USD","LU0058720904.USD","BK4588","AZN","LU0889565916.HKD","LU2462157665.USD","LU2237443895.HKD","LU2456880835.USD","LU2237443549.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653212202","title":"Astrazeneca PLC Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653212202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653212202?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:00","pubTimestamp":1784563200,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC slid 1.3% to SEK1,615.00 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,676.94.This was the stock's second consecutive day of losses.The company closed SEK310.50 below its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 236,711, compared to the 50-day average trading volume of 323,607.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 20, 2026 12:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU2237443549.SGD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","AZN","LU0708994859.HKD","BK4007","LU2456880835.USD","AZNH","LU2237443978.SGD","LU0310800379.SGD","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4568","LU1267930573.SGD","LU0058720904.USD","LU0128525929.USD","BK4585","BK4588","LU0432979614.USD","LU2237443622.USD","LU0889565916.HKD","LU0289739699.SGD","LU0029864427.USD","LU2237443382.USD","LU2237443895.HKD","LU1829250122.USD","LU0109394709.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652914152","title":"Market Chatter: AstraZeneca Unit Highlights Opportunities in Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2652914152","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652914152?lang=en_us&edition=fundamental","pubTime":"2026-07-20 17:39","pubTimestamp":1784540369,"startTime":"0","endTime":"0","summary":"AstraZeneca's  rare-disease arm Alexion said the field remains largely untapped, with about 95% of the roughly 10,000 identified rare diseases still lacking approved therapies, the Financial Times reported Monday, citing Chief Executive Marc Dunoyer.Advances in science are opening new avenues for drug development, Dunoyer was quoted as saying, adding that only about 500 rare diseases currently have modern treatments.Rare disease medicines accounted for 16% of AstraZeneca's $58.7 billion in revenue last year, underscoring the division's growing role as the company targets $80 billion in sales by 2030.AstraZeneca did not immediately respond to MT Newswires' request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443465.HKD","LU2237443549.SGD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","AZN","LU0708994859.HKD","BK4007","LU2456880835.USD","AZNH","LU2237443978.SGD","LU0310800379.SGD","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4568","LU1267930573.SGD","LU0058720904.USD","LU0128525929.USD","BK4585","BK4588","LU0432979614.USD","LU2237443622.USD","LU0889565916.HKD","LU0289739699.SGD","LU0029864427.USD","LU2237443382.USD","LU2237443895.HKD","LU1829250122.USD","LU0109394709.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284078","title":"AstraZeneca’s New Saruparib Trial Targets Next Wave of Prostate Cancer Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284078","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284078?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305874,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has launched EvoPAR-Prostate05, a Phase III study ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-new-saruparib-trial-targets-next-wave-of-prostate-cancer-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-new-saruparib-trial-targets-next-wave-of-prostate-cancer-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1829250122.USD","LU1267930573.SGD","LU2089984988.USD","LU0289739699.SGD","AZNH","LU0708994859.HKD","BK4588","BK4007","LU2462157665.USD","BK4568","LU0128525929.USD","LU2468319806.SGD","LU0109394709.USD","AZN","LU2237443382.USD","LU2237443622.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU0029864427.USD","LU2237443895.HKD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU0310800379.SGD","LU2237443465.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284044","title":"AstraZeneca’s ALICIA Real‑World CLL Study Wraps Up, Setting Up Fresh Data for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284044","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284044?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:30","pubTimestamp":1784305811,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The ALICIA study is an observational project tracking how acalabrutinib is...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-alicia-realworld-cll-study-wraps-up-setting-up-fresh-data-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-alicia-realworld-cll-study-wraps-up-setting-up-fresh-data-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU2468319806.SGD","LU2089984988.USD","LU2236285917.USD","BK4007","LU1267930573.SGD","LU0320765992.SGD","BK4588","LU2462157665.USD","LU2237443549.SGD","LU1829250122.USD","LU2456880835.USD","LU0432979614.USD","LU2237443382.USD","LU2237443622.USD","ISBC","LU0058720904.USD","LU0310800379.SGD","LU2237443978.SGD","LU0109394709.USD","BK4568","LU2417539215.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0708994859.HKD","BK4211","LU0289739699.SGD","LU0128525929.USD","AZN","LU2237443895.HKD","LU0029864427.USD","AZNH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652286740","title":"European Pharma Stocks' Underperformance Shouldn't Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2652286740","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652286740?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:13","pubTimestamp":1784297580,"startTime":"0","endTime":"0","summary":"1413 GMT - European pharma stocks are lagging behind the broader market, but the sector should benefit as investors start to look for trades beyond big tech, Intron Health's Naresh Chouhan and Dominic Rose say in a research note. This year's underperformance came after pricing deals with the Trump administration at the end of last year boosted the sector, Intron says. \"We do not believe investors have fallen out of love with pharma, it is just that many believe the sector is up with events for now,\" the analysts say. Upcoming strategy updates from companies like GSK, Novo Nordisk and Roche, and potential gains from AI should help pharma stocks, they add. Intron says it favors UCB, AstraZeneca, Roche and Novartis in the near term. The Stoxx Europe 600 Health Care index rises 0.3%.  Dow Jones NewswiresJuly 17, 2026 10:13 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","RHHBY","IE00BJJMRZ35.SGD","LU2237443895.HKD","MEDX","IE00B3T34201.USD","LU1093756325.SGD","THNR","LU2237443549.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4568","LU1093756168.USD","BK4599","LU2237443382.USD","LU1267930573.SGD","LU2236285917.USD","OZEM","IE00BKVL7J92.USD","IE0009355771.USD","NVO","LU2237443978.SGD","LU0154236417.USD","LU2468319806.SGD","AZNH","LU0211331839.USD","LU0070302665.USD","LU2417539215.USD","GSK","LU0320765489.SGD","LU0320765992.SGD","LU2089984988.USD","LU0058720904.USD","NVS","BK4007","03165","BK4532","CANC","LU0109394709.USD","IE00B4R5TH58.HKD","NVOX","LU2456880835.USD","PPH","LU0708994859.HKD","IE00BZ1G4Q59.USD","LU0029864427.USD","AZN","GSK.UK","HRTS","LU0128525929.USD","LU0208291251.USD","BK4578","LU0289739699.SGD","LU0889565916.HKD","LU2462157665.USD","IE00BFTCPJ56.SGD","LU0432979614.USD","LU0310800379.SGD","BK4585","BK4588","GSKH","LU2237443622.USD","NVOH","IE0002141913.USD","EPV","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652222334","title":"Morgan Stanley Remains a Buy on AstraZeneca (AZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652222334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652222334?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:35","pubTimestamp":1784234125,"startTime":"0","endTime":"0","summary":"In a report released today, Sarita Kapila from Morgan Stanley maintained a Buy rating on AstraZeneca, with a price target of p15,300.00. According ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-astrazeneca-azn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-remains-a-buy-on-astrazeneca-azn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU2236285917.USD","BK4007","LU2456880835.USD","LU0029864427.USD","LU1829250122.USD","LU0432979614.USD","LU1267930573.SGD","LU2237443382.USD","BK4588","LU0310800379.SGD","LU2089984988.USD","AZN","LU0109394709.USD","LU2462157665.USD","AZNH","LU0889565916.HKD","LU2237443622.USD","LU2237443465.HKD","LU2468319806.SGD","LU2237443549.SGD","LU2237443895.HKD","LU0128525929.USD","BK4568","LU0289739699.SGD","BK4585","IE00B3T34201.USD","LU0320765992.SGD","LU2417539215.USD","LU2237443978.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652787425","title":"AstraZeneca price target lowered to 15,300 GBp at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2652787425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652787425?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:30","pubTimestamp":1784219431,"startTime":"0","endTime":"0","summary":"Morgan Stanley lowered the firm’s price target on AstraZeneca (AZN) to 15,300 GBp from 16,500 GBp and keeps an Overweight rating on the shares. Pub...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-price-target-lowered-to-15300-gbp-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-price-target-lowered-to-15300-gbp-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1829250122.USD","LU1267930573.SGD","LU2089984988.USD","LU0289739699.SGD","AZNH","LU0708994859.HKD","BK4588","BK4007","LU2462157665.USD","BK4568","LU0128525929.USD","LU2468319806.SGD","LU0109394709.USD","AZN","LU2237443382.USD","LU2237443622.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU0029864427.USD","LU2237443895.HKD","LU0432979614.USD","LU0889565916.HKD","LU2236285917.USD","LU0310800379.SGD","LU2237443465.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652425804","title":"Astrazeneca PLC Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2652425804","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652425804?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:00","pubTimestamp":1784217600,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC rose 0.7% to SEK1,641.50 Thursday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,694.67.This was the stock's second consecutive day of gains.The company closed SEK284.00 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 320,096, compared to the 50-day average trading volume of 328,187.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 16, 2026 12:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU0029864427.USD","LU1829250122.USD","LU0310800379.SGD","LU2417539215.USD","LU2237443978.SGD","LU2237443465.HKD","BK4585","LU0708994859.HKD","LU0058720904.USD","IE00B3T34201.USD","LU2468319806.SGD","LU0432979614.USD","BK4588","LU0320765992.SGD","LU2237443549.SGD","LU2462157665.USD","LU2456880835.USD","LU2237443382.USD","LU2236285917.USD","LU2237443895.HKD","LU0889565916.HKD","LU0289739699.SGD","LU0109394709.USD","LU2089984988.USD","AZN","AZNH","LU0128525929.USD","LU1267930573.SGD","BK4007","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651446764","title":"AstraZeneca’s Eluminate-4 Trial Targets High-Risk Diabetes Patients, Raising Long-Term Upside for AZN","url":"https://stock-news.laohu8.com/highlight/detail?id=2651446764","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651446764?lang=en_us&edition=fundamental","pubTime":"2026-07-16 00:32","pubTimestamp":1784133152,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca is advancing a new Phase III study called Eluminate-4 to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-eluminate-4-trial-targets-high-risk-diabetes-patients-raising-long-term-upside-for-azn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-eluminate-4-trial-targets-high-risk-diabetes-patients-raising-long-term-upside-for-azn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU2236285917.USD","BK4007","LU2456880835.USD","LU0029864427.USD","LU1829250122.USD","LU0432979614.USD","LU1267930573.SGD","LU2237443382.USD","BK4588","LU0310800379.SGD","LU2089984988.USD","AZN","LU0109394709.USD","LU2462157665.USD","AZNH","LU0889565916.HKD","LU2237443622.USD","LU2237443465.HKD","LU2468319806.SGD","LU2237443549.SGD","LU2237443895.HKD","LU0128525929.USD","BK4568","LU0289739699.SGD","BK4585","IE00B3T34201.USD","LU0320765992.SGD","LU2417539215.USD","LU2237443978.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197435491","title":"Dizal Pharmaceutical Announces Uncertainty Regarding the Effectiveness of Its Licensing Agreement with AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1197435491","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197435491?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:05","pubTimestamp":1784106339,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical Co.,Ltd. (SH: 688192) has issued a stock price fluctuation announcement. The company recently entered into a licensing agreement with AstraZeneca UK Limited, granting AstraZeneca...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0432979614.USD","BK1161","09939","LU0310800379.SGD","LU2462157665.USD","LU0128525929.USD","LU1829250122.USD","LU0289739699.SGD","IE00B3T34201.USD","BK4007","BK0239","LU2236285917.USD","LU0320765992.SGD","LU2237443382.USD","LU2237443465.HKD","LU1267930573.SGD","LU2456880835.USD","BK4585","LU2237443978.SGD","LU2468319806.SGD","BK4568","BK1574","LU0889565916.HKD","LU2417539215.USD","BK4588","LU2237443622.USD","LU2237443549.SGD","BK1515","LU0708994859.HKD","LU2237443895.HKD","LU0058720904.USD","LU0029864427.USD","688192","159938","AZN","AZNH","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651824488","title":"AstraZeneca Advances AZD7760 Trial in Japan, Quietly Expanding Its Infection-Prevention Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2651824488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651824488?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:31","pubTimestamp":1784046665,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca plc (AZN) is running a new early-stage trial in Japan ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-azd7760-trial-in-japan-quietly-expanding-its-infection-prevention-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-azd7760-trial-in-japan-quietly-expanding-its-infection-prevention-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","LU2237443549.SGD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","AZN","LU0708994859.HKD","BK4007","LU2456880835.USD","AZNH","LU2237443978.SGD","LU0310800379.SGD","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4568","LU1267930573.SGD","LU0058720904.USD","LU0128525929.USD","BK4585","BK4588","LU0432979614.USD","LU2237443622.USD","LU0889565916.HKD","LU0289739699.SGD","LU0029864427.USD","LU2237443382.USD","LU2237443895.HKD","LU1829250122.USD","LU0109394709.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651100944","title":"Astrazeneca Slides Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2651100944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651100944?lang=en_us&edition=fundamental","pubTime":"2026-07-15 00:09","pubTimestamp":1784045340,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.AstraZeneca PLC  shares slid 1.95% to GBP123.64 Tuesday, on what proved to be an all-around favorable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU2236285917.USD","LU0708994859.HKD","LU1829250122.USD","LU2468319806.SGD","LU0058720904.USD","AZN","LU0889565916.HKD","LU0128525929.USD","BK4588","LU2237443549.SGD","LU0310800379.SGD","AZNH","LU0289739699.SGD","LU0109394709.USD","LU2237443465.HKD","LU1267930573.SGD","BK4568","LU0320765992.SGD","IE00B3T34201.USD","LU2089984988.USD","BK4007","LU2417539215.USD","LU2237443622.USD","LU2237443978.SGD","LU0432979614.USD","LU2462157665.USD","BK4585","LU0029864427.USD","LU2456880835.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651217978","title":"AstraZeneca to acquire rights to develop, commercialize Zegfrovy for $600M","url":"https://stock-news.laohu8.com/highlight/detail?id=2651217978","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651217978?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:40","pubTimestamp":1784022033,"startTime":"0","endTime":"0","summary":"Dizal announced that it has entered into a global exclusive license agreement with AstraZeneca (AZN) for Zegfrovy, an oral irreversible epidermal g...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-to-acquire-rights-to-develop-commercialize-zegfrovy-for-600m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-to-acquire-rights-to-develop-commercialize-zegfrovy-for-600m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","LU0058720904.USD","LU0310800379.SGD","BK4585","AZNH","LU2089984988.USD","LU2237443622.USD","LU0320765992.SGD","LU2237443382.USD","LU0708994859.HKD","LU0109394709.USD","LU2468319806.SGD","BK4007","LU0128525929.USD","LU2236285917.USD","LU0289739699.SGD","LU2417539215.USD","LU0432979614.USD","LU2237443465.HKD","IE00B3T34201.USD","LU1829250122.USD","LU2237443895.HKD","LU2456880835.USD","LU2462157665.USD","LU1267930573.SGD","LU2237443978.SGD","AZN","LU0029864427.USD","LU2237443549.SGD","BK4588","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651847179","title":"Astrazeneca Complements Lung-cancer Franchise with New Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2651847179","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651847179?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:24","pubTimestamp":1784021040,"startTime":"0","endTime":"0","summary":"0923 GMT - AstraZeneca is moving to complement its lung-cancer franchise through a licensing deal of up to $1.5 billion for a drug from China's Dizal Pharmaceutical, analysts at J.P. Morgan say in a research note. The deal makes strategic sense for the U.K. drugmaker given that it brings in a new product that complements its existing Tagrisso franchise in lung cancer, the analysts say. Under the deal, AstraZeneca is acquiring worldwide rights to develop and commercialize Dizal's Zegfrovy, which is approved in the U.S. and China for the treatment of a type of advanced non-small cell lung cancer. Zegfrovy is under review by the FDA for approval as an initial treatment and would compete directly with Johnson & Johnson's Rybrevant as an oral, chemotherapy-free treatment option, the analysts add. AstraZeneca shares fall 1.1%. Dow Jones NewswiresJuly 14, 2026 05:24 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2417539215.USD","AZN","LU0889565916.HKD","LU2237443382.USD","LU0320765992.SGD","BK4007","BK4568","IE00B3T34201.USD","LU0128525929.USD","LU1829250122.USD","LU2237443622.USD","AZNH","LU2237443978.SGD","LU2456880835.USD","LU2237443465.HKD","BK4585","LU0432979614.USD","LU1267930573.SGD","688192","LU2236285917.USD","LU2089984988.USD","LU0289739699.SGD","LU0058720904.USD","LU0708994859.HKD","LU2468319806.SGD","BK4588","LU0109394709.USD","LU0310800379.SGD","LU2462157665.USD","LU2237443895.HKD","LU2237443549.SGD","LU0029864427.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651317985","title":"AstraZeneca Licenses Zegfrovy From Dizal in Up to $1.5 Billion Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2651317985","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651317985?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:22","pubTimestamp":1784020949,"startTime":"0","endTime":"0","summary":"AstraZeneca (AZN) has entered a global licensing agreement to develop and commercialize Dizal Pharmaceutical's lung cancer drug Zegfrovy in a deal worth up to $1.5 billion, the company said Tuesday.Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0310800379.SGD","LU0109394709.USD","LU0029864427.USD","IE00B3T34201.USD","LU2237443465.HKD","BK4568","LU0289739699.SGD","LU2237443382.USD","LU2237443622.USD","LU0128525929.USD","LU0320765992.SGD","LU0432979614.USD","LU2417539215.USD","AZNH","LU2237443978.SGD","LU1267930573.SGD","LU0708994859.HKD","LU2089984988.USD","BK4007","LU2236285917.USD","LU1829250122.USD","LU0058720904.USD","BK4588","AZN","LU0889565916.HKD","LU2462157665.USD","LU2237443895.HKD","LU2456880835.USD","LU2237443549.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125551766","title":"Innovative Drug Stock Surges to 20% Daily Limit in 14 Seconds","url":"https://stock-news.laohu8.com/highlight/detail?id=1125551766","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125551766?lang=en_us&edition=fundamental","pubTime":"2026-07-14 14:21","pubTimestamp":1784010093,"startTime":"0","endTime":"0","summary":"Shares within the innovative drug sector experienced a sharp upward movement during Friday afternoon trading.Among individual stocks, Dizhe Pharmaceutical shares skyrocketed in a straight line,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","LU2237443549.SGD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","AZN","LU0708994859.HKD","BK4007","LU2456880835.USD","AZNH","LU2237443978.SGD","LU0310800379.SGD","IE00B3T34201.USD","LU2417539215.USD","LU2462157665.USD","BK4568","LU1267930573.SGD","LU0058720904.USD","LU0128525929.USD","BK4585","BK4588","LU0432979614.USD","LU2237443622.USD","LU0889565916.HKD","LU0289739699.SGD","LU0029864427.USD","LU2237443382.USD","LU2237443895.HKD","LU1829250122.USD","LU0109394709.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651432941","title":"AstraZeneca Advances AZD5004 Combo Data With Diabetes Drugs, Offering Subtle Upside for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651432941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651432941?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:30","pubTimestamp":1783960212,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s latest update covers a Phase 1 trial titled “An Open-l...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-azd5004-combo-data-with-diabetes-drugs-offering-subtle-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-azd5004-combo-data-with-diabetes-drugs-offering-subtle-upside-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","LU0320765992.SGD","BK4568","LU0432979614.USD","AZN","LU0109394709.USD","LU0310800379.SGD","LU2237443382.USD","LU0058720904.USD","LU0128525929.USD","BK4007","AZNH","LU0889565916.HKD","LU2417539215.USD","LU2237443549.SGD","LU2237443895.HKD","LU2468319806.SGD","LU2237443465.HKD","LU0708994859.HKD","LU2237443622.USD","LU0029864427.USD","LU2236285917.USD","BK4585","BK4588","LU1829250122.USD","BBC","LU2456880835.USD","LU0289739699.SGD","LU2237443978.SGD","LU2462157665.USD","LU1267930573.SGD","BK4211","LU2089984988.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143820","title":"Astrazeneca PLC Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143820?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:00","pubTimestamp":1783958400,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC dropped 1.8% to SEK1,641.50 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.2% to 2,704.89.This was the stock's fourth consecutive day of losses.The company closed SEK284.00 short of its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 521,505, compared to the 50-day average trading volume of 319,012.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 13, 2026 12:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","LU2237443465.HKD","LU0432979614.USD","IE00B3T34201.USD","LU2237443978.SGD","LU0889565916.HKD","LU0310800379.SGD","LU0128525929.USD","LU0109394709.USD","LU0289739699.SGD","BK4007","LU1267930573.SGD","LU2236285917.USD","BK4568","LU2089984988.USD","LU2237443622.USD","LU0058720904.USD","AZNH","LU2417539215.USD","LU2237443549.SGD","LU0320765992.SGD","LU2237443382.USD","LU2468319806.SGD","BK4585","LU2456880835.USD","LU2237443895.HKD","LU2462157665.USD","LU1829250122.USD","AZN","BK4588","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}